<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Pediatr</journal-id>
<journal-title-group>
<journal-title>BMC Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2431</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28472932</article-id>
<article-id pub-id-type="pmc">5418813</article-id>
<article-id pub-id-type="publisher-id">863</article-id>
<article-id pub-id-type="doi">10.1186/s12887-017-0863-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosome microarray analysis in the investigation of children with congenital heart disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Xiao-li</given-names>
</name>
<address>
<email>starwxl@foxmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Ru</given-names>
</name>
<address>
<email>linra020@126.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Fang</given-names>
</name>
<address>
<email>fuyingyi2008@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Min</given-names>
</name>
<address>
<email>cherry_pan999@hotmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Jin</given-names>
</name>
<address>
<email>hanjin1123@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xin</given-names>
</name>
<address>
<email>yangsunrise@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yong-ling</given-names>
</name>
<address>
<email>yonglingzhang@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Fa-tao</given-names>
</name>
<address>
<email>fataoli@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liao</surname>
<given-names>Can</given-names>
</name>
<address>
<phone>(+86) 2038076008</phone>
<email>canliao@hotmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8653 1072</institution-id><institution-id institution-id-type="GRID">grid.410737.6</institution-id><institution>Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center, </institution><institution>Guangzhou Medical University, </institution></institution-wrap>No. 9 Jinsui Road, Guangdong, China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>17</volume>
<elocation-id>117</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Our study was aimed to explore the clinical implication of chromosome microarray analysis (CMA) in genetically etiological diagnosis of children with congenital heart disease (CHD).</p>
</sec>
<sec>
<title>Methods</title>
<p>A total of 104 children with CHD with or without multiple congenital anomalies (MCA) or intellectual disabilities/developmental delay (ID/DD) but normal karyotype were investigated using Affymetrix CytoScan HD array.</p>
</sec>
<sec>
<title>Result</title>
<p>Pathogenic copy number variations (PCNVs) were identified in 29 children (27.9%). The detection rates in children with simple CHD and complex CHD were 31.1% (19/61) and 23.2% (10/43), respectively. The detection rates of PCNVs were 17.9% (7/39), 20% (5/25), 63.2% (12/19) and 23.8% (5/21) in isolated CHD, CHD plus MCA, CHD plus ID/DD, CHD plus MCA and ID/DD, respectively. The PCNVs rate of CHD plus ID/DD was significantly higher than that of isolated CHD. Two genomic loci including 15q11.2 deletion and 1q43-q44 deletion were considered as CHD locus. The <italic>DVL1, SKI, STIM1, CTNNA3</italic> and <italic>PLN</italic> were identified as candidate genes associated with CHD phenotypes.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>CMA can increase the diagnostic rate and improve the etiological diagnosis in children with CHD. We suggest CMA as a first-tier test in children with CHD, especially in children with CHD plus ID/DD.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>15q11.2 deletion</kwd>
<kwd>1q43-q44 deletion</kwd>
<kwd>Chromosome microarray analysis</kwd>
<kwd>Congenital heart disease</kwd>
<kwd>Copy number variation</kwd>
<kwd>Microdeletion/microduplication</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Science and technology project of Guangdong Province</institution>
</funding-source>
<award-id>2014A020213015</award-id>
<principal-award-recipient>
<name>
<surname>Li</surname>
<given-names>Ru</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>The key project of Guangzhou Science and Information Technology Bureau</institution>
</funding-source>
<award-id>201300000086</award-id>
</award-group>
<award-group>
<funding-source>
<institution>The key project of Guangzhou Health Bureau</institution>
</funding-source>
<award-id>201102A212026</award-id>
</award-group>
<award-group>
<funding-source>
<institution>Medical research foundation of Guangdong Province</institution>
</funding-source>
<award-id>A2013515</award-id>
<principal-award-recipient>
<name>
<surname>Pan</surname>
<given-names>Min</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Congenital heart disease (CHD) is one of the most common birth defects. The incidence of CHD in the neonate is 8-9/1000, and nearly 1.35 million CHD neonates were born every year in the whole world [<xref ref-type="bibr" rid="CR1">1</xref>]. Despite improvement of various treatment measures, CHD is still one of the major causes of children mortality.</p>
<p>The causes of CHD include non-genetic factors and genetic factors. Non-genetic factors include: environmental factors, maternal exposure and infection. Chromosomal causes of CHD include chromosome aneuploidies, like trisomy 21, and copy number variations (CNVs). Chromosomal aneuploidies represent 12.5% of CHD causes [<xref ref-type="bibr" rid="CR2">2</xref>]. The spectrum of CHD-related CNVs ranges from recurrent microdeletion and microduplication syndromes, like DiGeorge syndrome (22q11 deletion syndrome) and Williams-Beuren syndrome (7q11.23 deletion syndrome), which are associated with a distinct clinical recognizable phenotype, to rare CNVs, flanked by unique breakpoints [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>].</p>
<p>The resolution of conventional karyotype analysis is limited to 5 Mb or larger genomic imbalances [<xref ref-type="bibr" rid="CR6">6</xref>]. The drawback of fluorescence in situ hybridization (FISH) lies in its a targeted approach to detect chromosomal defects, rather than a genome-wide screening method like microarrays or MLPA [<xref ref-type="bibr" rid="CR7">7</xref>]. Chromosome Microarray Analysis (CMA) is a routine technique in clinical molecular testing nowadays, which contains two types of arrays: oligonucleotide arrays and Single Nucleotide Polymorphism arrays (SNP arrays). Both the arrays could detect genome-wide CNVs. Moreover, SNP arrays can detect the mosaicism, triploid, loss of heterozygosity (LOH) and uniparental disomy. In 2010, the American College of Medical Genetics issued practice guidelines for CMA, and pointed out that CMA was recommended as a first-tier test for postnatal patients with multiple congenital anomalies (MCA), intellectual disabilities/developmental delay (ID/DD) and autism spectrum disorders [<xref ref-type="bibr" rid="CR8">8</xref>]. Recently, CMA has been successfully applied to detect CNVs in patients with CHD, which confirmed the relationship between chromosome microdeletion/microduplication and CHD [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p>In this study, we present the results of genome-wide high resolution SNP array analysis in 106 children with CHD in the Chinese cohort, to explore the clinical implication of CMA in genetically etiological diagnosis of CHD.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Subjects and sample</title>
<p>In this study, we collected children diagnosed with CHD with or without MCA or ID/DD and normal karyotype at Guangzhou Women and Children’s Medical Center from January 2012 to December 2014. All the children were investigated by the complete cardiac evaluation, echocardiogram, medical history, physical examination, and/or operative reports. Considering patent ductus arteriosus (PDA) was common in children with CHD, the child with PDA was selected only if he/she was born at &gt;37 weeks’ gestational age and the PDA was unclosed after 6 weeks of life [<xref ref-type="bibr" rid="CR2">2</xref>]. MCA included cerebral malformation, neural tube and spine defects, craniofacial and neck abnormalities, thorax abnormalities, ventral wall defect, abdomen and gastrointestinal tract defects, genitourinary malformation and skeletal dysplasia. ID/DD was diagnosed by the pediatric specialist. The peripheral blood from these children and their parents were collected. Informed consent was obtained from all the participants. The study was approved by the ethics committees of Guangzhou Women and Children’s Medical Center.</p>
<p>According to the National Birth Defects Prevention Study [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], CHD was classified into the following types: septal defect, atrioventricular septal defect (AVSD), conotruncal defects, left ventricular outflow tract obstruction (LVOTO), right ventricular outflow tract obstruction (RVOTO), LVOTO + RVOTO, single ventricle (SV), and PDA (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Data of pathogenic copy number variants (PCNVs) in children with congenital heart disease (CHD) and CHD classification</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">CHD Classification</th><th colspan="3">Simple CHD</th><th colspan="3">Associate CHD</th><th colspan="3">Total</th></tr><tr><th>No. PCNVs</th><th>No. tested</th><th>PR (%)</th><th>No. PCNVs</th><th>No. tested</th><th>PR (%)</th><th>No. PCNVs</th><th>No. tested</th><th>PR (%)</th></tr></thead><tbody><tr><td>Septal defect</td><td>9</td><td>37</td><td>24.3</td><td>1</td><td>6</td><td>16.8</td><td>10</td><td>43</td><td>23.3</td></tr><tr><td> ASD</td><td>5</td><td>18</td><td>27.8</td><td>0</td><td>0</td><td>0</td><td>5</td><td>18</td><td>27.8</td></tr><tr><td> VSD</td><td>4</td><td>19</td><td>21.1</td><td>0</td><td>0</td><td>0</td><td>4</td><td>19</td><td>21.1</td></tr><tr><td> VSD + ASD</td><td>0</td><td>0</td><td>0</td><td>1</td><td>6</td><td>16.8</td><td>1</td><td>6</td><td>16.8</td></tr><tr><td>AVSD</td><td>0</td><td>1</td><td>0</td><td>0</td><td>2</td><td>0</td><td>0</td><td>3</td><td>0</td></tr><tr><td>Conotruncal defects</td><td>1</td><td>3</td><td>33.3</td><td>1</td><td>13</td><td>7.8</td><td>2</td><td>16</td><td>12.5</td></tr><tr><td> TOF</td><td>1</td><td>3</td><td>33.3</td><td>1</td><td>2</td><td>50</td><td>2</td><td>5</td><td>40</td></tr><tr><td> D-TGA</td><td>0</td><td>0</td><td>0</td><td>0</td><td>11</td><td>0</td><td>0</td><td>11</td><td>0</td></tr><tr><td>LVOTO</td><td>2</td><td>5</td><td>40</td><td>3</td><td>9</td><td>33.3</td><td>5</td><td>14</td><td>35.7</td></tr><tr><td> COA</td><td>0</td><td>2</td><td>0</td><td>1</td><td>4</td><td>25</td><td>1</td><td>6</td><td>16.7</td></tr><tr><td> AS</td><td>2</td><td>3</td><td>66.7</td><td>0</td><td>1</td><td>0</td><td>2</td><td>4</td><td>50</td></tr><tr><td> IAA, A</td><td>0</td><td>0</td><td>0</td><td>2</td><td>2</td><td>100</td><td>2</td><td>2</td><td>100</td></tr><tr><td> COA + AS</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>0</td><td>0</td><td>2</td><td>0</td></tr><tr><td>RVOTO</td><td>3</td><td>3</td><td>100</td><td>2</td><td>8</td><td>25</td><td>5</td><td>11</td><td>45.5</td></tr><tr><td> PS/PA</td><td>3</td><td>3</td><td>100</td><td>2</td><td>8</td><td>25</td><td>5</td><td>11</td><td>45.5</td></tr><tr><td>LVOTO + RVOTO</td><td>0</td><td>0</td><td>0</td><td>3</td><td>4</td><td>75</td><td>3</td><td>4</td><td>75</td></tr><tr><td> AS + PS</td><td>0</td><td>0</td><td>0</td><td>3</td><td>4</td><td>75</td><td>3</td><td>4</td><td>75</td></tr><tr><td>Single Ventricle</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>1</td><td>0</td></tr><tr><td>PDA</td><td>4</td><td>12</td><td>33.3</td><td>0</td><td>0</td><td>0</td><td>4</td><td>12</td><td>33.3</td></tr><tr><td>Total</td><td>19</td><td>62</td><td>30.6</td><td>10</td><td>43</td><td>23.2</td><td>29</td><td>104</td><td>27.9</td></tr></tbody></table><table-wrap-foot><p>
<italic>PR</italic> positive rate, <italic>ASD</italic> atrial septal defect, <italic>VSD</italic> ventricular septal defect, <italic>AVSD</italic> atrioventricular septal defect, <italic>TOF</italic> tetralogy of Fallot, <italic>D-TGA</italic> d-transposition of the great arteries, <italic>COA</italic> coarctation of the aorta, <italic>AS</italic> aortic stenosis, <italic>IAA</italic> interruption arterial arch, <italic>PS</italic> pulmonary stenosis, <italic>PA</italic> pulmonary atresia, <italic>PDA</italic> patent ductus arteriosus, <italic>LVOTO</italic> Left ventricular outflow tract obstruction, <italic>RVOTO</italic> Right ventricular outflow tract obstruction</p></table-wrap-foot></table-wrap>
</p>
<p>According to the complexity of CHD, CHD was divided into two groups: simple CHD and complex CHD [<xref ref-type="bibr" rid="CR22">22</xref>]. Simple CHD are defined as anatomically discrete (e.g., ventricular septal defect, VSD) or a well-recognized single entity (e.g., tetralogy of Fallot, TOF). Complex CHD are defined as combinations of different heart defects (single ventricle was included in this group).</p>
<p>According to whether the children with CHD have ID/DD and/or MCA, CHD was divided into two types: isolated CHD and syndromic CHD. The syndromic CHD contained CHD plus MCA, CHD plus ID/DD, and CHD plus MCA and ID/DD.</p>
</sec>
<sec id="Sec4">
<title>Chromosome microarray analysis</title>
<p>CMA was performed using Affymetrix CytoScan HD arrays according to manufacturer’s instructions. The procedure included genomic DNA extraction, digestion and ligation, PCR amplification, PCR product purification, quantification and fragmentation, labeling, array hybridization, washing and scanning. Data was analyzed with Chromosome Analysis Suite software version 1.2 (Affymetrix). The reporting threshold was set at 100 kb with marker count ≥50. CNVs were interpreted as benign listed in Database of Genomic Variants (DGV) database (<italic>n</italic> &gt; 3 studies or documented in &gt;1% of the normal population) or no gene included (not close to known CHD genes within 1 Mb) [<xref ref-type="bibr" rid="CR23">23</xref>]. CNVs was classified as pathogenic copy number variations (PCNVs) if these CNVs overlapped completely with the minimal critical region of a well-known microdeletion or microduplication syndrome, or if the CNV comprised a dosage-sensitive gene known to cause a similar phenotype, referring to ClinGen Dosage Sensitivity Map (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/">http://www.ncbi.nlm.nih.gov/projects/</ext-link>dbvar/clingen/). Rare CNVs (&lt;1% in normal population and without OMIM genes) that do not meet the criteria above, should be considered as variant of uncertain clinical significance (VOUS), until proven otherwise (e.g. by functional studies) [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. For interpretation of these results, our in-house database and the following public database were used: DGV (<ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation/">http://projects.tcag.ca/variation/</ext-link>), Cytogenomics Array Group CNV Database (<ext-link ext-link-type="uri" xlink:href="https://www.cagdb.org">https://www.cagdb.org</ext-link>), Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources database (DECIPHER, <ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk/">http://decipher.sanger.ac.uk/</ext-link>), Online Mendelian Inheritance in Man (OMIM, <ext-link ext-link-type="uri" xlink:href="http://www.omim.org">http://www.omim.org</ext-link>), University of California Santa Cruz (UCSC, <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>/, hg19), ClinVar (<ext-link ext-link-type="uri" xlink:href="http://www.clinvar.com">http://www.clinvar.com</ext-link>/) and CHD wiki (<ext-link ext-link-type="uri" xlink:href="http://homes.esat.kuleuven.be/~bioiuser/chdwiki/index.php/Main_Page">http://homes.esat.kuleuven.be/~bioiuser/chdwiki/index.php/Main_Page</ext-link>). All CNVs were further confirmed by Real-Time Polymerase Chain Reaction. Parental analysis were performed to interpret VOUS.</p>
</sec>
<sec id="Sec5">
<title>Statistical analysis</title>
<p>Statistical analyses were performed using the Statistic Package for Social Science (SPSS) 13.0 statistical software package (SPSS Inc.). The PCNVs detection rates in children with simple CHD and complex CHD were compared using chi square test. Frequencies of recurrent CNVs in this study and the control cohorts were compared using fisher’s exact test. <italic>P</italic> value &lt;0.05 was statistically significant. The PCNVs detection rates in isolated CHD, CHD plus MCA, CHD plus ID/DD, and CHD plus MCA and ID/DD were pairwise compared using chi square test or fisher’s exact test, <italic>p</italic> value &lt;0.008 was statistically significant.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Results</title>
<p>CMA was performed in 104 children (67 males and 37 females) with CHD aged from 5 days to 8 years old. CNVs were identified in 96.2% (100/104) of the children. The size of CNVs ranged from 102 kb to 13.8 Mb. CNVs were interpreted as benign or likely benign in 69.2% (72/104) children. The detection rate for PCNVs was 27.9% (29/104), and the VOUS rate was 2.9% (3/104) after parental analysis.</p>
<p>Detailed CHD classification and demographic data of the children were listed in Table <xref ref-type="table" rid="Tab1">1</xref>. The percentages of children with simple CHD and complex CHD were 58.7% (61/104) and 41.3% (43/104), respectively. PCNVs were identified in 31.1% (19/61) children with simple CHD and in 23.2% (10/43) children with complex CHD. Pearson Chi-square test showed that there was no significant difference between these two groups (<italic>P</italic> &gt; 0.05). PCNVs were detected in 23.3% (10/43) of septal defect, 0 (0/3) of AVSD, 12.5% (2/16) of conotruncal defects, 35.7% (5/14) of LVOTO, 45.5% (5/11) of RVOTO, 75% (3/4) of LVOTO + RVOTO, 0 (0/1) of SV, and 33.3% (4/12) of PDA.</p>
<p>The detection rates of PCNVs in isolated CHD and syndromic CHD were 17.9% (7/39) and 33.8% (22/65), respectively. There was no significant difference between these two groups (<italic>P</italic> &gt; 0.05). The detection rates for PCNVs were 20% (5/25) in CHD plus MCA, 63.2% (12/19) in CHD plus ID/DD, and 23.8% (5/21) in CHD plus MCA and ID/DD, respectively (Table <xref ref-type="table" rid="Tab2">2</xref>). The PCNVs rate of CHD plus ID/DD was significantly higher than that of isolated CHD (63.2 vs 17.9%, <italic>P =</italic> 0.001) and CHD plus MCA (63.2 vs 20%, <italic>P</italic> = 0.004).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Classification of children with CHD and/or other diagnoses (MCA, ID/DD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Classification of symptoms</th><th colspan="3">Simple CHD</th><th colspan="3">Complex CHD</th><th colspan="3">Total</th></tr><tr><th>No. pCNVs</th><th>No. tested</th><th>PR (%)</th><th>No. pCNVs</th><th>No. tested</th><th>PR (%)</th><th>No. pCNVs</th><th>No. tested</th><th>PR (%)</th></tr></thead><tbody><tr><td>Isolated CHD</td><td>3</td><td>15</td><td>20.0</td><td>4</td><td>24</td><td>16.7</td><td>7</td><td>39</td><td>17.9</td></tr><tr><td>Syndromic CHD</td><td>16</td><td>46</td><td>34.8</td><td>6</td><td>19</td><td>31.6</td><td>22</td><td>65</td><td>33.8</td></tr><tr><td> CHD + MCA</td><td>4</td><td>18</td><td>22.2</td><td>1</td><td>7</td><td>14.3</td><td>5</td><td>25</td><td>20</td></tr><tr><td> CHD+ ID/DD</td><td>8</td><td>13</td><td>61.5</td><td>4</td><td>6</td><td>66.7</td><td>12</td><td>19</td><td>63.2</td></tr><tr><td> CHD + MCA+ ID/DD</td><td>4</td><td>15</td><td>26.7</td><td>1</td><td>6</td><td>16.7</td><td>5</td><td>21</td><td>23.8</td></tr><tr><td>Total</td><td>19</td><td>61</td><td>31.1</td><td>10</td><td>43</td><td>23.2</td><td>29</td><td>104</td><td>27.9</td></tr></tbody></table><table-wrap-foot><p>
<italic>PR</italic> positive rate, <italic>MCA</italic> multiple congenital anomalies, <italic>ID/DD</italic> intellectual disabilities/development delay</p></table-wrap-foot></table-wrap>
</p>
<p>PCNVs were identified in 29 children (Table <xref ref-type="table" rid="Tab3">3</xref>, including 22q11 deletion syndrome (<italic>n</italic> = 6), 22q11 duplication syndrome (<italic>n</italic> = 1), Williams-Beuren syndrome (<italic>n</italic> = 6), Angleman/Prader-Willi syndrome (<italic>n</italic> = 1), Wolf-Hirschhorn syndrome (<italic>n</italic> = 2), Schinzel-Giedion midface retraction syndrome (<italic>n</italic> = 1), 15q24 recurrent microdeletion syndrome (<italic>n</italic> = 1), 1p36 microdeletion syndrome (<italic>n</italic> = 1), Cornelia de Lange syndrome 4(<italic>n</italic> = 1), Marfan syndrome (<italic>n</italic> = 1), Opitz G/BBB syndrome (<italic>n</italic> = 1), 6q24 LOH (<italic>n</italic> = 1), and CNVs overlapped with DECIPHER patient entries (<italic>n</italic> = 6).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Pathogenic copy number variants and variants of unknown significance detected by Chromosome Microarray Analysis in children with CHD</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Child</th><th rowspan="2">Age<sup>a</sup>
</th><th colspan="2">Phenotype</th><th rowspan="2">CNVs: Region and size</th><th rowspan="2">Known syndrome/Decipher number/OMIM number</th><th rowspan="2">Significant genes (bold fonts) /candidate genes relating to CHD<sup>b</sup>
</th></tr><tr><th>Cardiac diagnosis</th><th>MCA or ID/DD</th></tr></thead><tbody><tr><td colspan="7">Pathogenic CNVs</td></tr><tr><td rowspan="2"> 1</td><td rowspan="2">8 y</td><td rowspan="2">ASD</td><td rowspan="2">ID</td><td>Dup 11q24.2-q25 (8.5 Mb)</td><td>Decipher number 255590</td><td>None</td></tr><tr><td>Del 1q43-q44 (6.2 Mb)</td><td>Decipher number 284767</td><td>None</td></tr><tr><td> 2</td><td>7 m</td><td>PS + ASD</td><td>None</td><td>Del 22q11.21 (3.2 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td rowspan="3"> 3</td><td rowspan="3">10 m</td><td rowspan="3">PDA</td><td rowspan="3">Congenital anal atresia + DD</td><td>Dup 3p26.1-p24.3 (13.8 Mb)</td><td>Decipher number 260758</td><td>
<bold><italic>CRELD1</italic></bold>
<italic>;</italic>
<bold><italic>RAF1</italic></bold>
</td></tr><tr><td>Del 6q13-q14.1 (5.2 Mb)</td><td>Decipher number 249539</td><td>None</td></tr><tr><td>Dup 17q12 (1.4 Mb)</td><td>Decipher number 278456</td><td>None</td></tr><tr><td> 4</td><td>4 y</td><td>PDA</td><td>Leukodystrophy</td><td>Del 1p36.33-p36.31(4.8 Mb)</td><td>1p36 microdeletion syndrome</td><td>
<italic>DVL1;SKI</italic>
</td></tr><tr><td> 5</td><td>13 m</td><td>ASD</td><td>DD</td><td>Del 15q24.1-q24.2 (3.1 Mb)</td><td>15q24 recurrent microdeletion syndrome</td><td>
<bold><italic>STRA6</italic></bold>
</td></tr><tr><td> 6</td><td>5 y</td><td>PS</td><td>ID</td><td>Del 15q11.2-q13.1 (4.9 Mb)</td><td>Angelman/Prader-Willi syndrome</td><td>None</td></tr><tr><td> 7</td><td>5 m</td><td>VSD</td><td>DD</td><td>Del 4p16.3-p16.2 (5.7 Mb)</td><td>Wolf-Hirschhorn syndrome</td><td>
<bold><italic>EVC2; EVC</italic></bold>
</td></tr><tr><td> 8</td><td>2 m</td><td>ASD</td><td>Laryngeal cartilage dysplasia</td><td>Del 22q11.21 (2.4 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td> 9</td><td>2 y</td><td>VSD</td><td>ID</td><td>Del 22q11.21 (3.2 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td> 10</td><td>14 m</td><td>ASD</td><td>None</td><td>Del 22q11.21 (1.4 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td> 11</td><td>2 y</td><td>ASD</td><td>Cleft palate + ID</td><td>Dup 18q12.3 (0.64 Mb)</td><td>Schinzel-Giedion midface retraction syndrome</td><td>
<italic>SETBP1</italic>
</td></tr><tr><td align="char" char="×"> 12</td><td>2 y</td><td>AS + PS</td><td>DD</td><td>Del 7q11.23 (1.4 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 13</td><td>3 y</td><td>TOF + PLSVC + Pericardial defect</td><td>Diaphragmatic hernia + ID</td><td>Dup 2q12.3 (0.42 Mb)</td><td>Decipher number 287980</td><td>None</td></tr><tr><td> 14</td><td>1 m</td><td>IAA,A + VSD</td><td>fingers of both hands and left toe deformity</td><td>Dup Xp22.2 (0.72 Mb)</td><td>Opitz G/BBB syndrome</td><td>
<bold><italic>MID1</italic></bold>
</td></tr><tr><td> 15</td><td>1 y</td><td>PS + VSD</td><td>ID</td><td>Del 22q11.21 (3.2 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td rowspan="2"> 16</td><td rowspan="2">15 m</td><td rowspan="2">PDA</td><td rowspan="2">DD</td><td>Del 1p36.33 (0.35 Mb)</td><td>Decipher number 106</td><td>None</td></tr><tr><td>Dup 17q25.1-q25.3 (6.4 Mb)</td><td>Decipher number 249584</td><td>None</td></tr><tr><td> 17</td><td>18 m</td><td>ASD</td><td>Cleft palate + DD</td><td>Del 4p16.3-p16.1 (7.6 Mb)</td><td>Wolf-Hirschhorn Syndrome</td><td>
<bold><italic>EVC2; EVC</italic></bold>
</td></tr><tr><td> 18</td><td>11 d</td><td>IAA, A + VSD</td><td>None</td><td>Del 7q11.23 (1.4 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 19</td><td>8 m</td><td>AS + PS</td><td>DD</td><td>Del 7q11.23 (1.4 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 20</td><td>2 y</td><td>PS</td><td>None</td><td>Dup 15q21.1 (1.58 Mb)</td><td>Marfan syndrome</td><td>
<bold><italic>FBN1</italic></bold>
</td></tr><tr><td rowspan="2"> 21</td><td rowspan="2">3 y</td><td rowspan="2">TOF</td><td rowspan="2">Absence of corpus callosum + cerebellar vermis hypoplasia + ID</td><td>Del 1q43-q44 (7.6 Mb)</td><td>Decipher number 249647</td><td>None</td></tr><tr><td>Dup 10p15.3-p14 (6.7 Mb)</td><td>Decipher number 278831</td><td>None</td></tr><tr><td> 22</td><td>3 y</td><td>COA + VSD + ASD</td><td>ID</td><td>LOH 6q24.1-q24.2 (5.2 Mb)</td><td>Decipher number 290225</td><td>
<bold><italic>CITED2</italic></bold>
</td></tr><tr><td rowspan="2"> 23</td><td rowspan="2">1 m</td><td rowspan="2">AS</td><td rowspan="2">Hemivertebra + Adduction deformity of thumb + Polydactyly + Funnel chest</td><td>Del 8q23.3-q24.11(1.24 Mb)</td><td>Cornelia de Lange syndrome 4</td><td>
<italic>RAD21</italic>
</td></tr><tr><td>Dup 11p15.3-15.2 (0.75 Mb)</td><td>None</td><td>None</td></tr><tr><td> 24</td><td>2 y</td><td>VSD</td><td>ID</td><td>Del 22q11.21 (3.2 Mb)</td><td>22q11 deletion syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td> 25</td><td>2 y</td><td>PS</td><td>ID</td><td>Del 7q11.23 (1.5 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 26</td><td>2 m</td><td>AS</td><td>None</td><td>Del 7q11.23 (1.5 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 27</td><td>2 m</td><td>AS + PS</td><td>None</td><td>Del 7q11.23 (1.4 Mb)</td><td>Williams-Beuren syndrome</td><td>
<bold><italic>ELN</italic></bold>
</td></tr><tr><td> 28</td><td>7 m</td><td>PDA</td><td>Cleft palate</td><td>Dup 22q11.21 (2.5 Mb)</td><td>22q11 duplication syndrome</td><td>
<bold><italic>TBX1</italic></bold>
</td></tr><tr><td rowspan="2"> 29</td><td rowspan="2">6 m</td><td rowspan="2">ASD + VSD</td><td rowspan="2">None</td><td>Dup 17q25.1-q25.3 (8.5 Mb)</td><td>Decipher number 254723</td><td>None</td></tr><tr><td>Del 20q13.33 (1.3 Mb)</td><td>Decipher number 2615</td><td>None</td></tr><tr><td colspan="7">Variants of unknown significance</td></tr><tr><td> 30</td><td>1 m</td><td>CoA + Heart Enlargement</td><td>None</td><td>Dup 11p15.4 (0.18 Mb)</td><td>None</td><td>
<italic>STIM1</italic>
</td></tr><tr><td> 31</td><td>1 m</td><td>AS + VSD</td><td>None</td><td>Dup 10q21.3 (0.4 Mb)</td><td>None</td><td>
<italic>CTNNA3</italic>
</td></tr><tr><td> 32</td><td>1 m</td><td>D-TGA + VSD + ASD</td><td>None</td><td>Dup 6q22.31 (0.36 Mb)</td><td>None</td><td>
<italic>PLN</italic>
</td></tr></tbody></table><table-wrap-foot><p>
<italic>ASD</italic> atrial septal defect, <italic>PDA</italic> patent ductus arterious, <italic>PS</italic> pulmonary stenosis, <italic>VSD</italic> ventricular septal defect, <italic>TOF</italic> tetralogy of Fallot, <italic>PLSVC</italic> persistent left superior vena cava, <italic>AS</italic> aortic stenosis, <italic>IAA,A</italic> interruption arterial arch, A type, <italic>COA</italic> coarctation of the aorta, <italic>D-TGA</italic> d-transposition of the great arteries, <italic>DD</italic> development delay, <italic>ID</italic> intellectual disabilities</p><p>
<sup>a</sup>Age column: y, years; m, months; d, days</p><p>
<sup>b</sup>Accordion to CHD wiki (<ext-link ext-link-type="uri" xlink:href="http://homes.esat.kuleuven.be/~bioiuser/chdwiki/index.php/Main_Page">http://homes.esat.kuleuven.be/~bioiuser/chdwiki/index.php/Main_Page</ext-link>)and OMIM database (<ext-link ext-link-type="uri" xlink:href="http://www.omim.org">http://www.omim.org</ext-link>)</p></table-wrap-foot></table-wrap>
</p>
<p>In this study, PCNVs in 79.3% (23/29) of the children contained genes contributing to CHD (Table <xref ref-type="table" rid="Tab3">3</xref>). The genes responsible for syndromic CHD included <italic>TBX1</italic> (22q11 deletion syndrome), <italic>ELN</italic> (Williams-Beuren syndrome), <italic>EVC2</italic> and <italic>EVC</italic> (Wolf-Hirschhorn syndrome), <italic>STRA6</italic> (15q24 recurrent microdeletion syndrome), <italic>FBN1</italic> (Marfan syndrome), <italic>MID1</italic> (Opitz G/BBB syndrome), <italic>RAD21</italic> (Cornelia de Lange syndrome 4) and <italic>SETBP1</italic> (Schinzel-Giedion midface retraction). In addition, the genes contributing to non-syndromic CHD included <italic>CRELD1, RAF1</italic> and <italic>CITED2</italic>. D<italic>VL1</italic> and <italic>SKI</italic> were identified as candidate genes for CHD in the current study.</p>
<p>CNVs detected in 9 children were classified as VOUS initially, further parental microarray analysis showed that CNVs in 6 children were inherited. The remaining CNVs in the other 3 children (Table <xref ref-type="table" rid="Tab3">3</xref>, child 30-32) were de novo and the clinical significance was still unknown. Therefore, the VOUS rate was 2.8% in this study. The three VOUS were 11p15.4 duplication (chr11:3,923,985-4,242,111, 180 kb), 10q21.3 duplication (chr10:69,026,332-69,430,434, 400 kb) and 6q22.31 duplication (chr6:118,693,553-119,050,523, 360 kb). Three genes, <italic>STIM1</italic>, <italic>CTNNA3</italic> and <italic>PLN</italic> relevant with CHD, located in these fragments respectively. For the other children with benign or pathogenic CNVs, their parents rejected further parental analysis by CMA.</p>
</sec>
<sec id="Sec7">
<title>Discussion</title>
<p>In the past few years, several studies have investigated postnatal cases with syndromic CHD by array CGH (aCGH) (Table <xref ref-type="table" rid="Tab4">4</xref>) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. Different arrays were used in these studies, and the PCNVs detection rate ranged from 10.9 to 25.5%. Bachman’s study showed that the lowest PCNVs detection rate was 10.9% (5/46) using Roche NimbleGen 135 K arrays [<xref ref-type="bibr" rid="CR18">18</xref>]. The highest detection rate was 25.5% (5/20) by Agilent 244 K array from Syrmou’s study [<xref ref-type="bibr" rid="CR19">19</xref>]. In our study, the total detection rate for PCNVs reached 27.9% (29/104) by CytoScan HD array, including 1,950,000 oligonucleotide probes and 750,000 SNP probes. Our results demonstrated further that denser arrays with high resolution will lead to a proportional increase in number of PCNVs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].<table-wrap id="Tab4"><label>Table 4</label><caption><p>The comparison of studies in postnatal patients with isolate/syndromic CHD</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Study</th><th>Array type</th><th>No. tested</th><th>Other diagnosis</th><th>PCNVs rates</th><th>VOUS rates</th></tr></thead><tbody><tr><td>Thienpont et al. 2007 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td>1 Mb BAC</td><td>60</td><td>MCA, ID</td><td>16.7%</td><td>11.7%</td></tr><tr><td rowspan="2">Richards et al. 2008 [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td rowspan="2">385 K oligo arrays</td><td>20</td><td>MCA, DD/ID</td><td>25%</td><td rowspan="2">9.8%</td></tr><tr><td>20</td><td>None</td><td>0</td></tr><tr><td>Erdogan et al. 2008 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>1 Mb BAC or 1 × 244 K Agilent arrays</td><td>105</td><td>None</td><td>4.7%</td><td>Unknow</td></tr><tr><td>Greenway et al. 2009 [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td>Affymetrix SNP 6.0</td><td>114</td><td>None</td><td>5.3%</td><td>Unknow</td></tr><tr><td>Breckpot J et al. 2010 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>1 Mb array</td><td>150</td><td>MCA</td><td>17.3%</td><td>Unknow</td></tr><tr><td>Rauch et al. 2010 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td>100 K Affymetrix</td><td>19</td><td>MCA</td><td>21%</td><td>Unknow</td></tr><tr><td>Goldmuntz et al. 2011 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td>100 K Oligo array</td><td>58</td><td>MCA</td><td>20.7%</td><td>3.4%</td></tr><tr><td>Breckpot et al. 2011 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>Affymetrix SNP 6.0</td><td>46</td><td>None</td><td>4.3%</td><td>Unknow</td></tr><tr><td>Derwinska et al. 2012 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td>180 K Oligo</td><td>150</td><td>MCA</td><td>14%</td><td>Unknow</td></tr><tr><td>Syrmou et al. 2013 [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td>1 × 244 K or 4 × 180 K Agilent arrays</td><td>55</td><td>MCA</td><td>25.5%</td><td>Unknow</td></tr><tr><td>Bachman et al. 2013 [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>Roche NimbleGen 135 K arrays</td><td>46</td><td>MCA</td><td>10.9%</td><td>Unknow</td></tr><tr><td>Our study</td><td>Affymetrix CytoScan HD arrays</td><td>104</td><td>MCA, ID/DD</td><td>27.9%</td><td>2.9%</td></tr></tbody></table><table-wrap-foot><p>
<italic>BAC</italic> bacterial artificial chromosome, <italic>MCA</italic> multiple congenital anomalies, <italic>DD/ID</italic> development delay/intellectual disabilities, <italic>SNP</italic> single nucleotide polymorphism</p></table-wrap-foot></table-wrap>
</p>
<p>CMA has also been applied in children with isolated CHD previously [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The PCNVs detection rates ranged from 0 to 5.3% (Table <xref ref-type="table" rid="Tab4">4</xref>). Richards et al. studied 20 children with isolated CHD and 20 children with CHD plus MCA, the results showed that PCNVs detection rate in isolated CHD was 0 and that in CHD plus MCA was 25%, and the highest PCNVs detection rate was 45% in children with CHD plus neurologic defects [<xref ref-type="bibr" rid="CR11">11</xref>]. Therefore, CMA was not recommended by Richards for children with isolated CHD. In our study, PCNVs detection rate was 17.9% (7/39) in isolated CHD. The PCNVs detection rates for CHD plus MCA, CHD plus ID/DD and CHD plus MCA and ID/DD were 20, 63.2 and 23.8%, respectively. PCNVs detection rate in CHD plus ID/DD was significantly higher than that of isolated CHD (<italic>P</italic> = 0.001) and CHD plus MCA (<italic>P</italic> = 0.004). Our data demonstrated that CMA is the most useful for genetic diagnosis in children with CHD plus ID/DD. In addition, we also recommended CMA investigation for children with isolated CHD.</p>
<p>In this study, PCNVs were detected in 31.1% (19/61) children with simple CHD and 23.2% (10/43) children with complex CHD by CMA. There was no significant difference between the two groups (<italic>P</italic> &gt; 0.05). Detection rates in various types of CHD were different. Shaffer et al. reviewed 580 fetuses with CHD and normal karyotype by aCGH [<xref ref-type="bibr" rid="CR25">25</xref>], and revealed the detection rates of PCNVs as follows: 16.2% (11/68) in LVOTO, 11.6% (5/43) in conotruncal defect and 10.6% (14/132) in septal defect. The above three types of CHD in fetuses were the most frequent. In our study, the PCNVs detection rates in different types of CHD in isolated or with additional anomalies were as follows in turn: 75% (3/4) in LVOTO + RVOTO, 45.5% (5/11) in RVOTO, 35.7% (5/14) in LVOTO, 33.3% (4/12) in PDA, 23.3% (10/43) in septal defect, 12.5% (2/16) in conotruncal defects. Our data demonstrate that LVOTO and/or RVOTO were most probably related to microdeletion/microduplication. Of the 29 children with PCNVs, 22 (75.9%) were complicated with MCA and/or DD/ID. High detection rate in children with PDA (33.3%) was obtained in this study, and we noticed that all the 12 children with PDA were complicated with MCA and/or ID/DD. There was no PCNVs detected in children with AVSD (<italic>n</italic> = 2) and SV (<italic>n</italic> = 1), this may be due to the small sample size in our study.</p>
<p>Gijsbers et al. suggested that as the rising of aCGH resolution, there will be more VOUS identified [<xref ref-type="bibr" rid="CR26">26</xref>]. In the previous studies in children with CHD by microarray, the VOUS detection rates ranged from 3.4 to 11.7% [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. In this study, CNVs detected in 9 children were unknown of clinical significance. After parental microarray analysis, CNVs in 6 children were inherited, the remaining CNVs in the other 3 children (Table <xref ref-type="table" rid="Tab3">3</xref>, child 30-32) were de novo and the clinical significance was still unknown. Finally, the VOUS rate was 2.9% in our study, which did not increase obviously as the resolution rise compared with previous studies. Therefore, parental analysis could assist in interpreting CNVs and reducing VOUS rate.</p>
<p>The clinical features of 1p36 microdeletion syndrome include microcephaly, brachycephaly, developmental delay with hypotonia, seizures and cardiac defects [<xref ref-type="bibr" rid="CR27">27</xref>]. In our study, CMA revealed a 4.8 Mb deletion at 1p36.33-p36.31 (chr1:849,466-5,685,789) in child 4 with PDA and leukodystrophy, which contained the <italic>SKI</italic> and <italic>DVL1</italic> genes. <italic>SKI</italic> morphant embryos showed severe cardiac anomalies, especial complete failure in cardiac looping and malformations of the outflow tract [<xref ref-type="bibr" rid="CR28">28</xref>]. Researchers have studied <italic>DVL1</italic> null mice and reported that <italic>DVL1</italic>-mediated planar cell polarity signal was crucially for cardiac outflow tract development [<xref ref-type="bibr" rid="CR29">29</xref>]. Based on the above data, <italic>SKI</italic> and <italic>DVL1</italic> could be the main genes responsible for CHD phenotypes in 1p36 deletion syndrome.</p>
<p>A 4.9 Mb deletion at 15q11.2-q13.1 (chr15: 23,620,191- 28,540,345) was detected in child 6 (Table <xref ref-type="table" rid="Tab3">3</xref>) with pulmonary stenosis plus ID. He was diagnosed as Angelman/Prader-Willi syndrome, the clinical features include ID, microcephaly, seizures, truncal ataxia, feeding difficulties in infancy and muscular hypotonia. Soemedi et al. first reported the association of 15q11.2 deletion with CHD, in their study the phenotypes contained left-side malformations, coarctation of the aorta, septal defect and TOF [<xref ref-type="bibr" rid="CR30">30</xref>]. Geng et al. have detected four patients with 15q11.2 deletion (size range 245-2703 kb) in 502 CHD patients, their result also showed the 15q11.2 deletion has low penetrance in CHD patients [<xref ref-type="bibr" rid="CR31">31</xref>]. These data indicated that 15q11.2 deletion, containing the Angelman/Prader-Willi syndrome region, represents a critical CHD locus. However, further studies are need to ascertain the genes responsible for CHD.</p>
<p>In the present study, we identified two children with 1q43-q44 deletion. Child 1 manifested atrial septal defect (ASD) and ID. Child 21 manifested TOF and absence of corpus callosum. Our study showed significantly higher frequency of 1q43-q44 deletion (2/104) than that of the 9170 control cases (4/9170) (<italic>P</italic> = 0.002) [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Therefore, 1q43-q44 should be considered as a locus associated with cardiac development. The clinical features of 1q43-44 deletion syndrome include ID, language retardation, characteristic facial features, abnormalities of the corpus callosum and seizures [<xref ref-type="bibr" rid="CR33">33</xref>]. Summarizing the literature, patients with 1q43-q44 deletion manifesting ID/DD or structural anomaly of central nervous system (69/83, 83.1%) more frequently than CHD (19/76, 25%) (<italic>P</italic> &lt; 0.001, Table <xref ref-type="table" rid="Tab5">5</xref>). These data suggested 1q43-q44 deletion may have low penetrance in CHD children.<table-wrap id="Tab5"><label>Table 5</label><caption><p>1q43-q44 deletion in our study compared with other studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Phenotype</th><th>Our case</th><th>1q43 deletion<sup>a</sup>
</th><th>1q44 deletion<sup>b</sup>
</th><th>1q43-q44 deletion<sup>c</sup>
</th><th>1q42-q44 deletion<sup>d</sup>
</th><th>Total</th></tr></thead><tbody><tr><td>ID/DD or CNS abnormal</td><td>2/2</td><td>22/27</td><td>24/24</td><td>15/24</td><td>6/6</td><td>69/83</td></tr><tr><td>Congenital heart defects</td><td>2/2</td><td>8/24</td><td>5/22</td><td>2/24</td><td>2/4</td><td>19/76</td></tr></tbody></table><table-wrap-foot><p>
<italic>ID/DD</italic> intellectual disabilities/development delay, <italic>CNS</italic> central nervous system</p><p>
<sup>a</sup>Reference to [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]</p><p>
<sup>b</sup>Reference to [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]</p><p>
<sup>c</sup>Reference to [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]</p><p>
<sup>d</sup>Reference to [<xref ref-type="bibr" rid="CR44">44</xref>]</p></table-wrap-foot></table-wrap>
</p>
<p>The child 11, a girl with ASD and cleft palate which had been corrected surgically. She was diagnosed with mental retardation at 2 years old by pediatric doctor. CMA test revealed chromosome 18q12.3 duplication (chr18: 41,814,626- 42,453,303). <italic>SETBP1</italic> gene located in the fragment which was responsible for Schinzel-Giedion midface retraction syndrome, and point mutation is the most common type. The clinical features included severe mental retardation, distinctive facial features, and multiple congenital malformations such as skeletal abnormalities and cardiac defects. A dominant-negative or gain-of-function mechanism was proposed to underlie this syndrome [<xref ref-type="bibr" rid="CR34">34</xref>]. We sequenced the 5 exons of <italic>SETBP1</italic> gene, and no mutation was detected. The <italic>SETBP1</italic> gene duplication was in accordance with gain-of-function mechanism, and the child’s manifestations were similar with the phenotypes of Schinzel-Giedion midface retraction syndrome, Therefore, <italic>SETBP1</italic> should be the main responsible gene for this patient.</p>
<p>The child 22 had coarctation of aorta, VSD, ASD (cardiac surgery was performed when he was 1 month old) and ID. Brain MRI showed normal result. CMA test revealed a 5.2 Mb LOH on chromosome 6q24.1-q24.2 (chr6:139,184,381-144,411,648). This LOH fragment included <italic>PLAG1</italic> and <italic>HYMAI</italic> genes, which were associated with imprinting disorder intrauterine growth retardation and neonatal hyperglycemia [<xref ref-type="bibr" rid="CR35">35</xref>]. Another gene <italic>CITED2</italic> also located in the LOH, which has been identified associated with cardiac malformations, including atrial and ventricular septal defects, overriding aorta, double-outlet right ventricle and right-side aortic arches [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, this fragment was classified as PCNVs.</p>
<p>Of the 29 children with PCNVs, 7 (24.1%) were with 22q11 deletion (<italic>n</italic> = 6) or duplication (<italic>n</italic> = 1) syndrome, which was the most common type. The incidence of 22q11 deletion/duplication was 6.7% (7/104) in the children with CHD in the present study. These data indicate that in addition to CMA it could be more cost-effective to exclude 22q11 deletion/duplication firstly by targeted technique such as MLPA in children with CHD.</p>
<p>In the 3 children with VOUS, we identified CHD candidate genes such as <italic>STIM1, CTNNA3</italic> and <italic>PLN</italic>. <italic>STIM1</italic> gene mutation could cause cardiomyocyte hypertrophy [<xref ref-type="bibr" rid="CR37">37</xref>]. <italic>PLN</italic> gene mutation was associated with cardiomyopathy [<xref ref-type="bibr" rid="CR38">38</xref>]. <italic>CTNNA3</italic> gene mutation could cause arrhythmogenic right ventricular dysplasia, compound heterozygous deletion was related to ASD [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. However, the children’s symptoms in this study were inconsistency with genotypes in the database. Further study of these genes are still needed to evaluate the clinical implication.</p>
</sec>
<sec id="Sec8">
<title>Conclusion</title>
<p>CMA has been recommended as a first-tier clinical diagnosis test in patients with DD, ID and/or MCA [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Study from Bachman also recommended aCGH as a first-tier test in evaluation of neonates with CHD [<xref ref-type="bibr" rid="CR18">18</xref>]. In the present study, we obtained the highest detection rate in children with CHD plus ID/DD (63.2%), while in children with isolated CHD we still obtained relatively high detection rate (17.9%). Based on the above data, we suggest CMA as a first-tier test in children with CHD, especially in children with CHD plus ID/DD.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>aCGH</term>
<def>
<p>Array CGH</p>
</def>
</def-item>
<def-item>
<term>AOH</term>
<def>
<p>Absence of heterozygosity</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>Atrial septal defect</p>
</def>
</def-item>
<def-item>
<term>AVSD</term>
<def>
<p>Atrioventricular septal defect</p>
</def>
</def-item>
<def-item>
<term>CHD</term>
<def>
<p>Congenital heart disease</p>
</def>
</def-item>
<def-item>
<term>
<italic>CITED2</italic>
</term>
<def>
<p>Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2</p>
</def>
</def-item>
<def-item>
<term>CMA</term>
<def>
<p>Chromosome microarray analysis</p>
</def>
</def-item>
<def-item>
<term>CNVs</term>
<def>
<p>Copy number variations</p>
</def>
</def-item>
<def-item>
<term>
<italic>CRELD1</italic>
</term>
<def>
<p>Cysteine-rich with EGF-like domains 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>CTNNA3</italic>
</term>
<def>
<p>Catenin (cadherin-associated protein), alpha 3</p>
</def>
</def-item>
<def-item>
<term>
<italic>CYFIP1</italic>
</term>
<def>
<p>Cytoplasmic FMR1 interacting protein 1</p>
</def>
</def-item>
<def-item>
<term>DD</term>
<def>
<p>Developmental delay</p>
</def>
</def-item>
<def-item>
<term>DECIPHER</term>
<def>
<p>Database of chromosomal imbalance and phenotype in humans using ensembl resources</p>
</def>
</def-item>
<def-item>
<term>DGV</term>
<def>
<p>Database of genomic variants</p>
</def>
</def-item>
<def-item>
<term>
<italic>DVL1</italic>
</term>
<def>
<p>Dishevelled segment polarity protein 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>ELN</italic>
</term>
<def>
<p>Elastin</p>
</def>
</def-item>
<def-item>
<term>
<italic>EVC</italic>
</term>
<def>
<p>Ellis van Creveld syndrome</p>
</def>
</def-item>
<def-item>
<term>
<italic>EVC2</italic>
</term>
<def>
<p>Ellis van Creveld syndrome 2</p>
</def>
</def-item>
<def-item>
<term>
<italic>FBN1</italic>
</term>
<def>
<p>Fibrillin 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>HYMAI</italic>
</term>
<def>
<p>Hydatidiform mole associated and imprinted (non-protein coding)</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p>Intellectual disabilities</p>
</def>
</def-item>
<def-item>
<term>LVOTO</term>
<def>
<p>Left ventricular outflow tract obstruction</p>
</def>
</def-item>
<def-item>
<term>MCA</term>
<def>
<p>Multiple congenital anomalies</p>
</def>
</def-item>
<def-item>
<term>
<italic>MID1</italic>
</term>
<def>
<p>Midline 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>NIPA1</italic>
</term>
<def>
<p>Non imprinted in Prader-Willi/Angelman syndrome 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>NIPA2</italic>
</term>
<def>
<p>Mon imprinted in Prader-Willi/Angelman syndrome 2</p>
</def>
</def-item>
<def-item>
<term>OMIM</term>
<def>
<p>Online mendelian inheritance in man</p>
</def>
</def-item>
<def-item>
<term>PCNVs</term>
<def>
<p>Pathogenic copy number variations</p>
</def>
</def-item>
<def-item>
<term>PDA</term>
<def>
<p>Patent ductus arteriosus</p>
</def>
</def-item>
<def-item>
<term>
<italic>PLAG1</italic>
</term>
<def>
<p>Pleiomorphic adenoma gene 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>PLN</italic>
</term>
<def>
<p>Phospholamban</p>
</def>
</def-item>
<def-item>
<term>
<italic>RAD21</italic>
</term>
<def>
<p>RAD21 homolog</p>
</def>
</def-item>
<def-item>
<term>
<italic>RAF1</italic>
</term>
<def>
<p>Raf-1 proto-oncogene, serine/threonine kinase</p>
</def>
</def-item>
<def-item>
<term>RVOTO</term>
<def>
<p>Right ventricular outflow tract obstruction</p>
</def>
</def-item>
<def-item>
<term>
<italic>SETBP1</italic>
</term>
<def>
<p>SET binding protein 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>SKI</italic>
</term>
<def>
<p>SKI proto-oncogene</p>
</def>
</def-item>
<def-item>
<term>
<italic>STIM1</italic>
</term>
<def>
<p>Stromal interaction molecule 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>STRA6</italic>
</term>
<def>
<p>Stimulated by retinoic acid 6</p>
</def>
</def-item>
<def-item>
<term>SV</term>
<def>
<p>Single ventricle</p>
</def>
</def-item>
<def-item>
<term>
<italic>TBX1</italic>
</term>
<def>
<p>T-box 1</p>
</def>
</def-item>
<def-item>
<term>
<italic>TTN</italic>
</term>
<def>
<p>Titin</p>
</def>
</def-item>
<def-item>
<term>
<italic>TUBGCP5</italic>
</term>
<def>
<p>Tubulin, gamma complex associated protein 5</p>
</def>
</def-item>
<def-item>
<term>UCSC</term>
<def>
<p>University of California Santa Cruz</p>
</def>
</def-item>
<def-item>
<term>VOUS</term>
<def>
<p>Variant of uncertain clinical significance</p>
</def>
</def-item>
<def-item>
<term>VSD</term>
<def>
<p>Ventricular septal defect</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>We thank all the children and their family members for their interest and cooperation.</p>
<sec id="FPar1">
<title>Funding</title>
<p>This study was supported by Science and technology project of Guangdong Province (2014A020213015), the key project of Guangzhou Science and Information Technology Bureau (201300000086), the key project of Guangzhou Health Bureau (201102A212026) and Medical research foundation of Guangdong Province (A2013515).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>XL Wu contributed to the implementation of the study, analysis and writing of this manuscript. R Li supervised the development of the manuscript and contributed to the analysis and writing. F Fu, M Pan, J H and X Yang interviewed the participants and collected and collated the data. YL Zhang and FT Li contributed to the experiment and data analysis. C Liao contributed to the study design, initiated the study, and provided comments on the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not applicable. Written consents for the publication of the absolute ages have been given by the parents of the children.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>The study was approved by the ethics committees of Guangzhou Women and Children’s Medical Center, and written informed consents to participate and the obtainment of blood samples were given on behalf of the children by the parents. Written informed consents to participate were also given by the parents for their own participation in the study, including blood collection.</p>
</sec>
<sec id="FPar7">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Linde</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Konings</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Slager</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Witsenburg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Helbing</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Takkenberg</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis</article-title>
<source/>J Am Coll Cardiol
          <year>2011</year>
<volume>58</volume>
<issue>21</issue>
<fpage>2241</fpage>
<lpage>2247</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2011.08.025</pub-id>
<pub-id pub-id-type="pmid">22078432</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Botto</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Riehle-Colarusso</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Cragan</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of chromosomal abnormalities to congenital heart defects: a population-based study</article-title>
<source/>Pediatr Cardiol
          <year>2011</year>
<volume>32</volume>
<issue>8</issue>
<fpage>1147</fpage>
<lpage>1157</lpage>
<pub-id pub-id-type="doi">10.1007/s00246-011-0034-5</pub-id>
<pub-id pub-id-type="pmid">21728077</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindsay</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Vitelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morishima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice</article-title>
<source/>Nature
          <year>2001</year>
<volume>410</volume>
<issue>6824</issue>
<fpage>97</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1038/35065105</pub-id>
<pub-id pub-id-type="pmid">11242049</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yagi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Furutani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hamada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Asakawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Minoshima</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of TBX1 in human del22q11.2 syndrome</article-title>
<source/>Lancet
          <year>2003</year>
<volume>362</volume>
<issue>9393</issue>
<fpage>1366</fpage>
<lpage>1373</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(03)14632-6</pub-id>
<pub-id pub-id-type="pmid">14585638</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pober</surname>
<given-names>BR</given-names>
</name>
</person-group>
<article-title>Williams-Beuren syndrome</article-title>
<source/>N Engl J Med
          <year>2010</year>
<volume>362</volume>
<issue>3</issue>
<fpage>239</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra0903074</pub-id>
<pub-id pub-id-type="pmid">20089974</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<mixed-citation publication-type="other">ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol. 2009; 114(5): 1161-1163.</mixed-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pergament</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>New molecular techniques for chromosome analysis</article-title>
<source/>Baillieres Best Pract Res Clin Obstet Gynaecol
          <year>2000</year>
<volume>14</volume>
<issue>4</issue>
<fpage>677</fpage>
<lpage>690</lpage>
<pub-id pub-id-type="doi">10.1053/beog.1999.0104</pub-id>
<pub-id pub-id-type="pmid">10985938</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hudgins</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Professional</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guidelines</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<issue>11</issue>
<fpage>742</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181f8baad</pub-id>
<pub-id pub-id-type="pmid">20962661</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thienpont</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>L</given-names>
</name>
<name>
<surname>de Ravel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Eyskens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boshoff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients</article-title>
<source/>Eur Heart J
          <year>2007</year>
<volume>28</volume>
<issue>22</issue>
<fpage>2778</fpage>
<lpage>2784</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehl560</pub-id>
<pub-id pub-id-type="pmid">17384091</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erdogan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tumer</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease</article-title>
<source/>J Med Genet
          <year>2008</year>
<volume>45</volume>
<issue>11</issue>
<fpage>704</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2008.058776</pub-id>
<pub-id pub-id-type="pmid">18713793</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Crider</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>NS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cryptic chromosomal abnormalities identified in children with congenital heart disease</article-title>
<source/>Pediatr Res
          <year>2008</year>
<volume>64</volume>
<issue>4</issue>
<fpage>358</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1203/PDR.0b013e31818095d0</pub-id>
<pub-id pub-id-type="pmid">18535492</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenway</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>DePalma</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Mesquita</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot</article-title>
<source/>Nat Genet
          <year>2009</year>
<volume>41</volume>
<issue>8</issue>
<fpage>931</fpage>
<lpage>935</lpage>
<pub-id pub-id-type="doi">10.1038/ng.415</pub-id>
<pub-id pub-id-type="pmid">19597493</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breckpot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thienpont</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Ravel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rayyan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Array comparative genomic hybridization as a diagnostic tool for syndromic heart defects</article-title>
<source/>J Pediatr
          <year>2010</year>
<volume>156</volume>
<issue>5</issue>
<fpage>810</fpage>
<lpage>817</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2009.11.049</pub-id>
<pub-id pub-id-type="pmid">20138633</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hofbeck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zweier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Trautmann</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot</article-title>
<source/>J Med Genet
          <year>2010</year>
<volume>47</volume>
<issue>5</issue>
<fpage>321</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2009.070391</pub-id>
<pub-id pub-id-type="pmid">19948535</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breckpot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thienpont</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Arens</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tranchevent</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Vermeesch</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Moreau</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects</article-title>
<source/>Cytogenet Genome Res
          <year>2011</year>
<volume>135</volume>
<issue>3-4</issue>
<fpage>251</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1159/000331272</pub-id>
<pub-id pub-id-type="pmid">21921585</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldmuntz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Paluru</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Biegel</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>White</surname>
<given-names>PS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies</article-title>
<source/>Congenit Heart Dis
          <year>2011</year>
<volume>6</volume>
<issue>6</issue>
<fpage>592</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1111/j.1747-0803.2011.00582.x</pub-id>
<pub-id pub-id-type="pmid">22010865</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Derwinska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bartnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wisniowiecka-Kowalnik</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jagla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rudzinski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pietrzyk</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of the role of copy-number variants in 150 patients with congenital heart defects</article-title>
<source/>Med Wieku Rozwoj
          <year>2012</year>
<volume>16</volume>
<issue>3</issue>
<fpage>175</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">23378395</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<mixed-citation publication-type="other">Bachman KK, Deward SJ, Chrysostomou C, Munoz R, Madan-Khetarpal S. Array CGH as a first-tier test for neonates with congenital heart disease. Cardiol Young. 2013:1–8.</mixed-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syrmou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tzetis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fryssira</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kosma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oikonomakis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Giannikou</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Array comparative genomic hybridization as a clinical diagnostic tool in syndromic and nonsyndromic congenital heart disease</article-title>
<source/>Pediatr Res
          <year>2013</year>
<volume>73</volume>
<issue>6</issue>
<fpage>772</fpage>
<lpage>776</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2013.41</pub-id>
<pub-id pub-id-type="pmid">23481551</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Lynberg</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Anderka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The National Birth Defects Prevention Study</article-title>
<source/>Public Health Rep
          <year>2001</year>
<volume>116</volume>
<issue>Suppl 1</issue>
<fpage>32</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1093/phr/116.S1.32</pub-id>
<pub-id pub-id-type="pmid">11889273</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Olney</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Keppler-Noreuil</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Guidelines for case classification for the National Birth Defects Prevention Study</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <year>2003</year>
<volume>67</volume>
<issue>3</issue>
<fpage>193</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.10012</pub-id>
<pub-id pub-id-type="pmid">12797461</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botto</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Riehle-Colarusso</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Seeking causes: classifying and evaluating congenital heart defects in etiologic studies</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <year>2007</year>
<volume>79</volume>
<issue>10</issue>
<fpage>714</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20403</pub-id>
<pub-id pub-id-type="pmid">17729292</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Thorland</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Quintero-Rivera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>South</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>Working Group of the American College of medical genetics laboratory quality assurance C. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants</article-title>
<source/>Genet Med
          <year>2011</year>
<volume>13</volume>
<issue>7</issue>
<fpage>680</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3182217a3a</pub-id>
<pub-id pub-id-type="pmid">21681106</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sagoo</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Sanderson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaw-Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects</article-title>
<source/>Genet Med
          <year>2009</year>
<volume>11</volume>
<issue>3</issue>
<fpage>139</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e318194ee8f</pub-id>
<pub-id pub-id-type="pmid">19367186</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Dabell</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Coppinger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bandholz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ellison</surname>
<given-names>JW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound</article-title>
<source/>Prenat Diagn
          <year>2012</year>
<volume>32</volume>
<issue>10</issue>
<fpage>986</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="doi">10.1002/pd.3943</pub-id>
<pub-id pub-id-type="pmid">22847778</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gijsbers</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Schoumans</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ruivenkamp</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Interpretation of array comparative genome hybridization data: a major challenge</article-title>
<source/>Cytogenet Genome Res
          <year>2011</year>
<volume>135</volume>
<issue>3-4</issue>
<fpage>222</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1159/000334066</pub-id>
<pub-id pub-id-type="pmid">22086107</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heilstedt</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Kashork</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality</article-title>
<source/>Clin Genet
          <year>2003</year>
<volume>64</volume>
<issue>4</issue>
<fpage>310</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0004.2003.00126.x</pub-id>
<pub-id pub-id-type="pmid">12974736</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doyle</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Bessling</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Maragh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Schepers</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<issue>11</issue>
<fpage>1249</fpage>
<lpage>1254</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2421</pub-id>
<pub-id pub-id-type="pmid">23023332</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wynshaw-Boris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Disheveled mediated planar cell polarity signaling is required in the second heart field lineage for outflow tract morphogenesis</article-title>
<source/>Dev Biol
          <year>2012</year>
<volume>370</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2012.07.023</pub-id>
<pub-id pub-id-type="pmid">22841628</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soemedi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Bentham</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Darlay</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Topf</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zelenika</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease</article-title>
<source/>Am J Hum Genet
          <year>2012</year>
<volume>91</volume>
<issue>3</issue>
<fpage>489</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.08.003</pub-id>
<pub-id pub-id-type="pmid">22939634</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Picker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hisama</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield</article-title>
<source/>BMC Genomics
          <year>2014</year>
<volume>15</volume>
<issue>1</issue>
<fpage>1127</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-15-1127</pub-id>
<pub-id pub-id-type="pmid">25516202</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A copy number variation morbidity map of developmental delay</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>9</issue>
<fpage>838</fpage>
<lpage>846</lpage>
<pub-id pub-id-type="doi">10.1038/ng.909</pub-id>
<pub-id pub-id-type="pmid">21841781</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Traylor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Ladda</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44</article-title>
<source/>Hum Genet
          <year>2012</year>
<volume>131</volume>
<issue>1</issue>
<fpage>145</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-011-1073-y</pub-id>
<pub-id pub-id-type="pmid">21800092</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arts</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Lier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Steehouwer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations of SETBP1 cause Schinzel-Giedion syndrome</article-title>
<source/>Nat Genet
          <year>2010</year>
<volume>42</volume>
<issue>6</issue>
<fpage>483</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1038/ng.581</pub-id>
<pub-id pub-id-type="pmid">20436468</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Conlin</surname>
<given-names>LK</given-names>
</name>
</person-group>
<article-title>Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations</article-title>
<source/>Clin Lab Med
          <year>2011</year>
<volume>31</volume>
<issue>4</issue>
<fpage>595</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1016/j.cll.2011.08.003</pub-id>
<pub-id pub-id-type="pmid">22118739</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamforth</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Braganca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eloranta</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Kranc</surname>
<given-names>KR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator</article-title>
<source/>Nat Genet
          <year>2001</year>
<volume>29</volume>
<issue>4</issue>
<fpage>469</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1038/ng768</pub-id>
<pub-id pub-id-type="pmid">11694877</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henke</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Toutzaris</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zanger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Methner</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Stromal interaction molecule 1 (STIM1) is involved in the regulation of mitochondrial shape and bioenergetics and plays a role in oxidative stress</article-title>
<source/>J Biol Chem
          <year>2012</year>
<volume>287</volume>
<issue>50</issue>
<fpage>42042</fpage>
<lpage>42052</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.417212</pub-id>
<pub-id pub-id-type="pmid">23076152</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitt</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kamisago</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asahi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mende</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban</article-title>
<source/>Science
          <year>2003</year>
<volume>299</volume>
<issue>5611</issue>
<fpage>1410</fpage>
<lpage>1413</lpage>
<pub-id pub-id-type="doi">10.1126/science.1081578</pub-id>
<pub-id pub-id-type="pmid">12610310</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Hengel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Calore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bauce</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dazzo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mazzotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>De Bortoli</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy</article-title>
<source/>Eur Heart J
          <year>2013</year>
<volume>34</volume>
<issue>3</issue>
<fpage>201</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehs373</pub-id>
<pub-id pub-id-type="pmid">23136403</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ceroni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lomartire</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giannandrea</surname>
<given-names>M</given-names>
</name>
<name>
<surname>D'Adamo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A CTNNA3 compound heterozygous deletion implicates a role for alphaT-catenin in susceptibility to autism spectrum disorder</article-title>
<source/>J Neurodev Disord
          <year>2014</year>
<volume>6</volume>
<issue>1</issue>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-17</pub-id>
<pub-id pub-id-type="pmid">25050139</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>NP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<issue>5</issue>
<fpage>749</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20466091</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Carlo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Volpe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pansini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nanna</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Valenzano</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FISH and cytogenetic characterization of a terminal chromosome 1q deletion: clinical case report and phenotypic implications</article-title>
<source/>Am J Med Genet A
          <year>2003</year>
<volume>117A</volume>
<issue>3</issue>
<fpage>251</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.10018</pub-id>
<pub-id pub-id-type="pmid">12599188</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Garraway</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Bodell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sellers</surname>
<given-names>WR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A 2-Mb critical region implicated in the microcephaly associated with terminal 1q deletion syndrome</article-title>
<source/>Am J Med Genet A
          <year>2007</year>
<volume>143A</volume>
<issue>15</issue>
<fpage>1692</fpage>
<lpage>1698</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.31776</pub-id>
<pub-id pub-id-type="pmid">17603806</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiraki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kanemura</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two new cases of pure 1q terminal deletion presenting with brain malformations</article-title>
<source/>Am J Med Genet A
          <year>2008</year>
<volume>146A</volume>
<issue>10</issue>
<fpage>1241</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.32275</pub-id>
<pub-id pub-id-type="pmid">18384145</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Guengoer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mau-Holzmann</surname>
<given-names>UA</given-names>
</name>
<name>
<surname>Maden</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hoopmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abele</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal diagnosis of a fetus with terminal deletion of chromosome 1 (q43) in first-trimester screening: is there a characteristic antenatal 1q deletion phenotype? A case report and review of the literature</article-title>
<source/>Fetal Diagn Ther
          <year>2011</year>
<volume>29</volume>
<issue>3</issue>
<fpage>253</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1159/000322421</pub-id>
<pub-id pub-id-type="pmid">21150175</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Kimonis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Irons</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Clinical presentation of 13 patients with subtelomeric rearrangements and a review of the literature</article-title>
<source/>Am J Med Genet A
          <year>2004</year>
<volume>128A</volume>
<issue>4</issue>
<fpage>352</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.30142</pub-id>
<pub-id pub-id-type="pmid">15264280</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thierry</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Beneteau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pichon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Flori</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Isidor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Popelard</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures</article-title>
<source/>Am J Med Genet A
          <year>2012</year>
<volume>158A</volume>
<issue>7</issue>
<fpage>1633</fpage>
<lpage>1640</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35423</pub-id>
<pub-id pub-id-type="pmid">22678713</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YY</given-names>
</name>
</person-group>
<article-title>A chromosome 1q44 deletion in a 4-months-old girl; the first report in Korea</article-title>
<source/>Korean J Pediatr
          <year>2014</year>
<volume>57</volume>
<issue>6</issue>
<fpage>292</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.3345/kjp.2014.57.6.292</pub-id>
<pub-id pub-id-type="pmid">25076975</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Homfray</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Smithson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype?</article-title>
<source/>J Med Genet
          <year>2001</year>
<volume>38</volume>
<issue>3</issue>
<fpage>175</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.38.3.175</pub-id>
<pub-id pub-id-type="pmid">11303509</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>